Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000874716-15-000015
Filing Date
2015-10-28
Accepted
2015-10-28 15:28:37
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q c716-20150930x10q.htm 10-Q 3396245
2 EX-31.1 c716-20150930xex311.htm EX-31.1 19820
3 EX-31.2 c716-20150930xex312.htm EX-31.2 19358
4 EX-32.1 c716-20150930xex321.htm EX-32.1 9998
5 EX-32.2 c716-20150930xex322.htm EX-32.2 10189
  Complete submission text file 0000874716-15-000015.txt   10869835

Data Files

Seq Description Document Type Size
6 EX-101.INS c716-20150930.xml EX-101.INS 2766551
7 EX-101.SCH c716-20150930.xsd EX-101.SCH 40284
8 EX-101.CAL c716-20150930_cal.xml EX-101.CAL 73794
9 EX-101.DEF c716-20150930_def.xml EX-101.DEF 113827
10 EX-101.LAB c716-20150930_lab.xml EX-101.LAB 326550
11 EX-101.PRE c716-20150930_pre.xml EX-101.PRE 304139
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19271 | Film No.: 151180121
SIC: 2835 In Vitro & In Vivo Diagnostic Substances